相关实验视频

Updated: Jun 10, 2025

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

埃尔宾:阻断瘤转移的一个重要的治疗点

Tingting Qiu¹, Liquan Tan², Jialong Yan³

¹Department of hematopathology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China.

Frontiers in pharmacology

|October 11, 2024

概括

埃尔宾蛋白的损失破坏了它与ESAM的相互作用,增加了甲的释放,并抑制了结肠直肠癌肺转移. 这表明Erbin是瘤转移的潜在治疗标.

科学领域:

分子生物学分子生物学
在瘤学瘤学.
细胞生物学细胞生物学

背景情况:

埃尔宾是一种适应蛋白,在上皮细胞中与ERBB2相互作用.
埃尔宾影响细胞增殖,细胞亡和自.
埃尔宾与败血症和乳腺癌,AML,HCC和CRC等癌症有关.

研究的目的:

调查Erbin在结直肠癌 (CRC) 转移中的作用.
阐明埃尔宾影响瘤进展的分子机制.

主要方法:

这项研究分析了Erbin与内皮细胞特异粘附分子 (ESAM) 之间的相互作用.
研究了Erbin损失对B细胞中甲 (Acar) 释放和线粒体功能的影响.
评估了这些变化对CRC肺转移的影响.

主要成果:

丢失Erbin取消了与ESAM的相互作用,导致Acar释放的增加.
埃尔宾缺乏促进了B细胞中的线粒体氧化酸化.
这些分子变化最终会抑制CRC的肺转移.

结论:

埃尔宾在调节阿卡尔释放和线粒体功能方面发挥着至关重要的作用.
埃尔宾-ESAM相互作用对于控制CRC肺转移至关重要.
埃尔宾代表了治疗瘤转移的新型治疗标.

关键词:

埃尔宾 (Erbin) 是一个非常有价值的人.抗瘤免疫力免疫力转移转移转移转移血小板血小板是瘤是一个瘤.

更多相关视频

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.